Second-line amrubicin vs topotecan in extensive-disease small cell lung cancer (ED-SCLC) sensitive to first-line platinum-based chemotherapy: updated results of a randomized phase 2 trial

被引：0
|
作者：
Jotte, R. [1 ]
Conkling, P. R. [2 ]
Reynolds, C. [3 ]
Shah, C. [4 ]
Galsky, M. [5 ]
Klein, L.
Fitzgibbons, J. F. [6 ]
McNally, R. [7 ]
Oliver, J. W. [8 ]
Renschler, M. [8 ]
机构：
[1] Rocky Mt Canc Ctr US Oncol, Denver, CO USA
[2] Virginia Oncol Associates US Oncol, Norfolk, VA USA
[3] Ocala Oncol Ctr US Oncol, Ocala, FL USA
[4] SUNY Upstate Med Univ, Syracuse, NY USA
[5] Nevada US Oncol, Ctr Comprehens Canc, Las Vegas, NV USA
[6] Sacred Heart Med Ctr US Oncol, Spokane, WA USA
[7] Celgene Corp, Biostat, Summit, NJ USA
[8] Celgene Corp, Clin Dev, Summit, NJ USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71833-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：540 / 541
页数：2
相关论文
共 50 条
  • [21] Phase II study of topotecan (T) and paclitaxel (P) as first-line treatment in patients (pts) with extensive disease small cell lung cancer (ED-SCLC)
    Hainsworth, J
    Palmer, M
    Granick, J
    Boston, B
    Bonomi, P
    Althouse, D
    Dharan, B
    Poulin, R
    Wissel, P
    LUNG CANCER, 2005, 49 : S320 - S320
  • [22] A phase III study of rovalpituzumab tesirine maintenance therapy following first-line platinum-based chemotherapy in patients with extensive disease small cell lung cancer (ED SCLC).
    Komarnitsky, Philip B.
    Lee, Ho-Jin
    Shah, Manan
    Wong, Shekman
    Gauthier, Sanja
    Dziubinski, Juliann
    Osbaugh, Stacy
    Zhang, Fan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Phase II study of roniciclib in combination with cisplatin/etoposide or carboplatin/etoposide as first-line therapy in subjects with extensive-disease small cell lung cancer (ED-SCLC)
    Reck, M.
    Horn, L.
    Novello, S.
    Barlesi, F.
    Albert, I.
    Juhasz, E.
    Chung, J.
    Fritsch, A.
    Drews, U.
    Rutstein, M.
    Wagner, A.
    Govindan, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Current standards and promising innovations in second-line drug therapy of extensive disease small cell lung cancer (ED-SCLC)
    Pogorzelski, Michael
    Schuler, Martin
    ONKOLOGIE, 2024, 30 (09): : 809 - 816
  • [25] A RANDOMIZED PHASE II TRIAL OF CELECOXIB COMBINED WITH PLATINUM-BASED CHEMOTHERAPY AS FIRST-LINE AND WITH ICOTINIB AS SECOND-LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Chu, Tianqing
    Han, Baohui
    Jiang, Liyan
    Zhong, Hua
    Gu, Aiqin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S612 - S613
  • [26] Phase I trial of the novel epothilone sagopilone (ZK-EPO) in combination with cisplatin as first-line therapy in patients with extensive-disease small-cell lung cancer (ED-SCLC)
    Gauler, T. C.
    Christoph, D. C.
    Gamarra, F.
    Fuhr, H.
    Gonschorek, C.
    Giurescu, M.
    Frickhofen, N.
    Huber, R. M.
    Schuler, M.
    Eberhardt, W. E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer
    Igawa, Satoshi
    Ono, Taihei
    Kasajima, Masashi
    Manabe, Hideaki
    Fukui, Tomoya
    Mitsufuji, Hisashi
    Yokoba, Masanori
    Kubota, Masaru
    Katagiri, Masato
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4911 - 4921
  • [28] Randomized Phase II Study of Belotecan or Topotecan as Second-Line Chemotherapy after Platinum Based Chemotherapy for Small Cell Lung Cancer
    Yoon, Shinkyo
    Lee, Dae Ho
    Choi, Chang-Min
    Lee, Jae Cheol
    Lee, Jung-Shin
    Kim, Sang We
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S787 - S788
  • [29] Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer
    von Pawel, Joachim
    Jotte, Robert
    Spigel, David R.
    O'Brien, Mary E. R.
    Socinski, Mark A.
    Mezger, Joerg
    Steins, Martin
    Bosquee, Leon
    Bubis, Jeffrey
    Nackaerts, Kristiaan
    Trigo, Jose M.
    Clingan, Philip
    Schuette, Wolfgang
    Lorigan, Paul
    Reck, Martin
    Domine, Manuel
    Shepherd, Frances A.
    Li, Shaoyi
    Renschler, Markus F.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (35) : 4012 - U160
  • [30] Phase I trial of sagopilone in combination with cisplatin as 1st-line therapy in patients with extensive-disease small-cell lung cancer (ED-SCLC)
    Christoph, D. C.
    Gauler, T. C.
    Gamarra, F.
    Fuhr, H. G.
    Fischer, J. R.
    Gonschorek, C.
    Frickhofen, N.
    Huber, R. M.
    Schuler, M.
    Eberhardt, W. E. E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 542 - 542
12345